tiprankstipranks
Trending News
More News >
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market

VistaGen Therapeutics (VTGN) Technical Analysis

Compare
821 Followers

Technical Sentiment

Overall Consensus
Sell
8Bullish
3Neutral
11Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
VistaGen Therapeutics’s (VTGN) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting VistaGen Therapeutics is a Sell.
VistaGen Therapeutics’s (VTGN) 20-Day exponential moving average is 2.28, while VistaGen Therapeutics’s (VTGN) share price is $2.34, making it a Buy.
VistaGen Therapeutics’s (VTGN) 50-Day exponential moving average is 2.44, while VistaGen Therapeutics’s (VTGN) share price is $2.34, making it a Sell.

VistaGen Therapeutics (VTGN) Pivot Points

May 03, 2025, 05:45 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.07
2.13
2.24
2.30
2.41
2.47
2.58
Fibonacci
2.13
2.20
2.24
2.30
2.37
2.41
2.47
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

VistaGen Therapeutics (VTGN) Moving Averages

May 03, 2025, 05:45 AM
Period
Simple
Exponential
MA5
2.30Buy
2.31Buy
MA10
2.23Buy
2.27Buy
MA20
2.19Buy
2.28Buy
MA50
2.49Sell
2.44Sell
MA100
2.64Sell
2.62Sell
MA200
2.91Sell
2.94Sell
VistaGen Therapeutics’s (VTGN) 10-Day exponential moving average is 2.27, while VistaGen Therapeutics’s (VTGN) share price is $2.34, making it a Buy.
VistaGen Therapeutics’s (VTGN) 100-Day exponential moving average is 2.62, while VistaGen Therapeutics’s (VTGN) share price is $2.34, making it a Sell.
VistaGen Therapeutics’s (VTGN) stock price is $2.34 and VistaGen Therapeutics’s (VTGN) 50-day simple moving average is 2.49, creating a Sell signal.
VistaGen Therapeutics’s (VTGN) stock price is $2.34 and VistaGen Therapeutics’s (VTGN) 100-day simple moving average is 2.64, creating a Sell signal.
VistaGen Therapeutics’s (VTGN) stock price is $2.34 and VistaGen Therapeutics’s (VTGN) 200-day simple moving average is 2.91, creating a Sell signal.

VistaGen Therapeutics (VTGN) Technical Indicators

May 03, 2025, 05:45 AM
Name
Value
Implied Action
RSI (14)
52.16
Neutral
STOCH (9,6)
91.10
Sell
STOCHRSI (14)
92.17
Sell
MACD (12,26)
-0.05
Sell
ADX (14)
23.22
Neutral
Williams %R
-4.82
Sell
CCI (14)
104.04
Sell
ATR (14)
0.15
-
Ultimate Oscillator
66.46
Neutral
ROC
15.12
Buy
VistaGen Therapeutics’s (VTGN) Relative Strength Index (RSI) is 52.16, creating a Neutral signal.
VistaGen Therapeutics’s (VTGN) Trend Strength Indicator (ADX) is 23.22, creating a Neutral signal.
VistaGen Therapeutics’s (VTGN) Commodity Channel Index (CCI) is 104.04, creating a Sell signal.
VistaGen Therapeutics’s (VTGN) Price Rate of Change (ROC) is 15.12, creating a Buy signal.

FAQ

Is VTGN a Buy, Hold, or Sell?
Based on VTGN’s technical indicators, VTGN is a Sell.
    What is VTGN’s RSI (14)?
    VTGN’s RSI (14) is 52.16, which suggests VTGN is a Neutral.
      What is VTGN’s MACD?
      VTGN’s MACD is -0.05, which suggests VTGN is a Sell.
        What is VTGN’s 5-day moving average?
        VTGN’s 5-day moving average is 2.30, which suggests VTGN is a Buy.
          What is VTGN’s 20-day moving average?
          VTGN 20-day moving average is 2.19, which suggests VTGN is a Buy.
            What is VTGN’s 50-day moving average?
            VTGN’s 50-day moving average is 2.49, which suggests VTGN is a Sell.
              What is VTGN’s 200-day moving average?
              VTGN’s 200-day moving average is 2.91, which suggests VTGN is a Sell.
                What is VTGN’s Williams % R (14)?
                VTGN’s Williams % R (14) is -4.82, which suggests VTGN is a Sell.
                  What is VTGN’s CCI (14)?
                  VTGN’s CCI (14) is 104.04, which suggests VTGN is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis